iifl-logo-icon 1

Aarti Pharmalabs Ltd Share Price

658.75
(-4.27%)
Nov 8, 2024|03:32:19 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open688.1
  • Day's High692
  • 52 Wk High721.7
  • Prev. Close688.1
  • Day's Low655.15
  • 52 Wk Low 380.05
  • Turnover (lac)881.41
  • P/E30.24
  • Face Value5
  • Book Value189.4
  • EPS22.75
  • Mkt. Cap (Cr.)5,969.99
  • Div. Yield0.44
View All Historical Data
No Records Found

Aarti Pharmalabs Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

688.1

Prev. Close

688.1

Turnover(Lac.)

881.41

Day's High

692

Day's Low

655.15

52 Week's High

721.7

52 Week's Low

380.05

Book Value

189.4

Face Value

5

Mkt Cap (₹ Cr.)

5,969.99

P/E

30.24

EPS

22.75

Divi. Yield

0.44

Aarti Pharmalabs Ltd Corporate Action

13 May 2024

12:00 AM

Dividend

Dividend Amount: 1

Record Date: 31 Jul, 2024

arrow

15 Jul 2024

12:00 AM

AGM

Announcement Date: 15 Jul, 2024

arrow

21 Oct 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Aarti Pharmalabs Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Aarti Pharmalabs Ltd SHAREHOLDING SNAPSHOT

10 Nov, 2024|11:32 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.17%

Foreign: 0.17%

Indian: 45.93%

Non-Promoter- 18.73%

Institutions: 18.73%

Non-Institutions: 35.16%

Custodian: 0.00%

Share Price

Aarti Pharmalabs Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

45.31

45.31

45.56

0.25

Preference Capital

0

0

0

0

Reserves

1,576.15

1,393.27

1,238.71

-0.02

Net Worth

1,621.46

1,438.58

1,284.27

0.23

Minority Interest

View Balance Sheet

No Record Found

View Profit & Loss

No Record Found

View Cash Flow

No Record Found

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

1,852.61

1,945.23

1,199.94

0

Excise Duty

0

0

0

0

Net Sales

1,852.61

1,945.23

1,199.94

0

Other Operating Income

0

0

0

0

Other Income

4.9

2.32

2.51

0

Aarti Pharmalabs Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,809.6

155.924,29,840.86863.290.755,123.6798.33

Divis Laboratories Ltd

DIVISLAB

5,949.85

95.231,58,179.454300.52,063507.93

Cipla Ltd

CIPLA

1,592.6

30.011,27,063.031,178.160.833,969.86360.74

Mankind Pharma Ltd

MANKIND

2,659.5

54.51,09,233.62634.4302,529.74269.24

Dr Reddys Laboratories Ltd

DRREDDY

1,283.65

22.331,07,397.831,882.10.626,678.8322.48

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Aarti Pharmalabs Ltd

Management

Register Office

Registrar Office

Chairman

Rashesh C Gogri

Vice Chairperson & MD

Hetal Gogri Gala

Managing Director

Narendra Jagannath Salvi

Non-Exec & Non-Independent Dir

Rajendra V Gogri

Non Executive Director

Parimal H Desai

Independent Director

Bhavesh R Vora

Independent Director

Vinay Gopal Nayak

Independent Director

Vilas G Gaikar

Independent Director

Jeenal Savla

Independent Director

Rupal Vora

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India.In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022.The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021. Pursuant to the said Demerger Scheme, Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly, all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date.Thereafter, the Company in 2023 commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023.9,06,26,008 Equity Shares of Rs 5/- each got listed effective January 30, 2023.
Read More

Company FAQs

What is the Aarti Pharmalabs Ltd share price today?

The Aarti Pharmalabs Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹658.75 today.

What is the Market Cap of Aarti Pharmalabs Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aarti Pharmalabs Ltd is ₹5969.99 Cr. as of 08 Nov ‘24

What is the PE and PB ratio of Aarti Pharmalabs Ltd?

The PE and PB ratios of Aarti Pharmalabs Ltd is 30.24 and 3.65 as of 08 Nov ‘24

What is the 52 Week High and Low of Aarti Pharmalabs Ltd?

The 52-week high/low is the highest and lowest price at which a Aarti Pharmalabs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Aarti Pharmalabs Ltd is ₹380.05 and ₹721.7 as of 08 Nov ‘24

What is the CAGR of Aarti Pharmalabs Ltd?

Aarti Pharmalabs Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 65.35%, 6 Month at 34.03%, 3 Month at 15.16% and 1 Month at 16.54%.

What is the shareholding pattern of Aarti Pharmalabs Ltd?

The shareholding pattern of Aarti Pharmalabs Ltd is as follows:
Promoters - 46.10 %
Institutions - 18.74 %
Public - 35.16 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp